safety Archives -

Sarepta shares yo-yo as FDA places hold on Duchenne trial

Phil Taylor Duchenne muscular dystrophy, Exondys 51, fda, rare disease, regulatory, safety, Sarepta, vesleteplirsen 0 Comment

Shares in Sarepta came under pressure after the biotech said it had temporarily halted a clinical trial of

Sarepta shares yo-yo as FDA places hold on Duchenne trial

https://pharmaphorum.com/news/sarepta-shares-yo-yo-as-fda-places-hold-on-duchenne-trial/

News/ News/ Patients

Is COVID in pregnancy linked to infant development issues?

Phil Taylor coronavirus, COVID-19, pregnancy, safety 0 Comment

Babies born to mothers who contracted COVID-19 during seem to be at slightly higher risk of neurodevelopmental delays,

Is COVID in pregnancy linked to infant development issues?

https://pharmaphorum.com/news/is-covid-in-pregnancy-linked-to-infant-development-issues/

Boehringer Ingelheim, Biberach, Germany, February 2007

Digital/ News/ News

Boehringer sells drug safety software to ArisGlobal

Phil Taylor ArisGlobal, Boehringer Ingelheim, digital, digital health, pharmacovigilance, safety 0 Comment

German drugmaker Boehringer Ingelheim has sold an artificial intelligence-powered software platform it developed to monitor drug safety data

Boehringer sells drug safety software to ArisGlobal

https://pharmaphorum.com/news/boehringer-sells-drug-safety-software-to-arisglobal/

News/ News/ R&D

Astellas takes $170m charge as it drops DMD gene therapies

Phil Taylor Astellas, Duchenne muscular dystrophy, gene therapy, safety 0 Comment

Astellas has said it will book a $170 million impairment charge in its fourth quarter results as a

Astellas takes $170m charge as it drops DMD gene therapies

https://pharmaphorum.com/news/astellas-takes-170m-charge-as-it-drops-dmd-gene-therapies/

News/ News/ News/ Oncology/ R&D

Gilead cleared to restart trials of CD47 drug magrolimab

Phil Taylor CD47, Gilead Sciences, Haematology, immuno-oncology, magrolimab, Oncology, safety 0 Comment

Gilead Sciences can restart pivotal trials of its cancer antibody magrolimab – the centrepiece of its $4.9 billion acquisition of

Gilead cleared to restart trials of CD47 drug magrolimab

https://pharmaphorum.com/news/gilead-cleared-to-restart-trials-of-cd47-drug-magrolimab/

Digital innovation drives vaccine development

News/ News/ Patients

COVID vaccines not linked to excess deaths, says CDC

Phil Taylor BioNTech, Comirnaty, coronavirus, COVID-19, COVID-19 vaccine, Moderna, Pfizer, safety, Spikevax 0 Comment

There is no evidence that vaccination with either the Pfizer/BioNTech or Moderna’s mRNA-based COVID-19 vaccines led to the

COVID vaccines not linked to excess deaths, says CDC

https://pharmaphorum.com/news/covid-vaccines-not-linked-to-excess-deaths-says-cdc/

News/ News/ R&D

GSK’s halts RSV vaccine trials in pregnant women after pause

Phil Taylor GlaxoSmithKline, pregnancy, respiratory syncytial virus, safety, vaccine 0 Comment

It looks like GlaxoSmithKline’s concerns about its respiratory syncytial virus (RSV) vaccine in pregnant women aren’t going to

GSK’s halts RSV vaccine trials in pregnant women after pause

https://pharmaphorum.com/news/gsks-halts-rsv-vaccine-trials-in-pregnant-women-after-pause/

News/ News/ R&D

Safety probe prompts GSK to halt RSV jab study in pregnant women

Phil Taylor GlaxoSmithKline, pregnancy, respiratory syncytial virus, safety, vaccine 0 Comment

GlaxoSmithKline has a lot riding on its respiratory syncytial virus (RSV) vaccine, which it thinks could be a

Safety probe prompts GSK to halt RSV jab study in pregnant women

https://pharmaphorum.com/news/safety-probe-prompts-gsk-to-halt-rsv-jab-study-in-pregnant-women/

Digital/ News/ News

Merck will assess Quris’ AI ‘patient-on-a-chip’ drug safety tech

Phil Taylor artificial intelligence, BioAI, digital, digital health, drug discovery, Merck KGaA, Quris, safety, Toxicology 0 Comment

German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that

Merck will assess Quris’ AI ‘patient-on-a-chip’ drug safety tech

https://pharmaphorum.com/news/merck-will-assess-quris-ai-patient-on-a-chip-drug-safety/

Trending

safety

Login